Platelet and Plasma Market Insights, Competitive Landscape, and Market Forecast

Description

Introduction

Platelets and plasma are essential to modern medicine, supporting transfusion care in surgery, trauma and oncology while also serving as the raw material for life-saving plasma-derived therapies. The market covers the collection, processing and supply of platelet concentrates, transfusable plasma, source plasma for fractionation and related components. In 2026, the market is valued at US$18.6 Bn and is projected to reach US$29.9 Bn by 2033, registering a CAGR of 7.02%. Demand is being shaped by rising use of immunoglobulin and other plasma-derived medicines, which require ever larger volumes of collected plasma. At the same time, hospitals and blood services are adopting safer and longer-lasting platelet products to reduce infection risk and wastage. Collection is becoming more automated, processing technologies are advancing, and governments are paying closer attention to supply security. These changes are moving the market toward higher value per unit while making donor recruitment and supply resilience central strategic concerns for collectors, fractionators and health systems alike.

Market Insights

The market is segmented by product type, collection method, processing technology and end user. Product types include platelet concentrates, fresh frozen plasma and plasma for transfusion, source plasma for fractionation, and cryoprecipitate and other plasma components. Collection methods span apheresis, whole blood derived collection, and hybrid and automated multicomponent collection. Processing technologies range from conventional processing and leukoreduction to pathogen reduction, cold-stored and extended shelf-life platelets, and freeze-dried and lyophilised plasma. End users include plasma fractionation companies, hospitals and transfusion services, blood banks and blood centres, and research and diagnostic laboratories. Between 2020 and 2025, the supply chain grew at about 6.2% CAGR, and the forecast period points to somewhat faster expansion. Pathogen reduction technology is the fastest-growing processing route at 11.2% CAGR, reflecting the push for safer transfusion products. Hybrid and automated multicomponent collection is also gaining ground at 9.6% CAGR, as collectors seek to obtain more usable product from each donor visit with greater efficiency.

Drivers

The strongest driver is the rising consumption of immunoglobulin, which pulls fractionators toward ever greater volumes of source plasma. This is a high-impact force over the long term, as immunoglobulin is used across a widening range of immune and neurological conditions and each patient requires repeated treatment. Fractionators therefore need a steady increase in collected litres to meet demand. The second driver is the regulatory and clinical adoption of pathogen reduction, which has medium impact over the medium term. By lowering the risk of transfusion-transmitted infections and, in some cases, extending shelf life, pathogen-reduced platelets carry higher value per unit and are gaining acceptance in blood services. Growth is not without obstacles. Supply depends heavily on donors, and source plasma collection is geographically imbalanced, a high-impact, long-term restraint. In addition, the cost of donor screening, testing and maintaining a cold chain for short-dated components weighs on collectors and blood centres, adding pressure on margins during the forecast period.

Business Opportunity

Domestic plasma collection programmes outside the United States represent a significant opening. Many countries depend on imported plasma or finished products, and governments are increasingly seeking local feedstock to strengthen supply security. New European rules on substances of human origin provide a legal anchor for expanding collection, encouraging investment in donor centres, apheresis equipment and fractionation agreements. Collectors, device suppliers and fractionators that help build these national programmes can secure long-term volumes and partnerships. A second opportunity lies in cold-stored and extended shelf-life platelets. Conventional platelets must be used within a few days, which complicates supply for trauma care and for rural or remote hospitals. Products that can be stored longer or kept refrigerated could open a dedicated trauma and rural supply segment. This segment is still small and being defined, so early movers have room to shape clinical practice, logistics models and pricing as hospitals and military users evaluate how such products fit into their transfusion strategies.

Region Analysis

North America leads the market with a 44.0% share in 2026, supported by a large network of source plasma collection centres, high immunoglobulin use and established transfusion services. Europe holds 25%, where blood services are adopting pathogen reduction and policymakers are working to increase domestic plasma collection under new rules. Asia Pacific accounts for 21% and is the fastest-growing region at 8.9% CAGR, as expanding healthcare access, larger patient populations and growing demand for plasma-derived therapies encourage investment in collection and processing capacity. Latin America represents 6% of the market, with demand rising through improved hospital infrastructure and national blood programmes. The Middle East and Africa holds a 4% share, where transfusion services are developing and supply often depends on imports. Across these five regions, donor availability, regulatory frameworks and the ability to build local collection capacity will determine how balanced global supply becomes, and regions that reduce dependence on imported plasma are likely to gain strategic importance over the forecast period.

Key Players

Grifols, S.A.
CSL Limited
Takeda Pharmaceutical Company Limited
Octapharma AG
Terumo Blood and Cell Technologies
Haemonetics Corporation
Fresenius Kabi AG
Cerus Corporation
Macopharma SAS
Kedrion S.p.A.

Segmentation

By Product Type:

Platelet Concentrates
Fresh Frozen Plasma and Plasma for Transfusion
Source Plasma for Fractionation
Cryoprecipitate and Other Plasma Components

By Collection Method:

Apheresis Collection
Whole Blood Derived Collection
Hybrid and Automated Multicomponent Collection

By Processing Technology:

Conventional Processing and Leukoreduction
Pathogen Reduction Technology
Cold-Stored and Extended Shelf-Life Platelets
Freeze-Dried and Lyophilized Plasma

By End User:

Plasma Fractionation Companies
Hospitals and Transfusion Services
Blood Banks and Blood Centers
Research and Diagnostic Laboratories

By Geographic Coverage:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

1. Executive Summary

1.1. Global Platelet and Plasma Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors

3. Global Platelet and Plasma Market Outlook, 2020-2033

3.1. Global Platelet and Plasma Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 3.1.1. Platelet Concentrates
- 3.1.2. Fresh Frozen Plasma and Plasma for Transfusion
- 3.1.3. Source Plasma for Fractionation
- 3.1.4. Cryoprecipitate and Other Plasma Components
3.2. Global Platelet and Plasma Market Outlook, by Collection Method, Value (US$ Bn), 2020-2033
- 3.2.1. Apheresis Collection
- 3.2.2. Whole Blood Derived Collection
- 3.2.3. Hybrid and Automated Multicomponent Collection
3.3. Global Platelet and Plasma Market Outlook, by Processing Technology, Value (US$ Bn), 2020-2033
- 3.3.1. Conventional Processing and Leukoreduction
- 3.3.2. Pathogen Reduction Technology
- 3.3.3. Cold-Stored and Extended Shelf-Life Platelets
- 3.3.4. Freeze-Dried and Lyophilized Plasma
3.4. Global Platelet and Plasma Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.4.1. Plasma Fractionation Companies
- 3.4.2. Hospitals and Transfusion Services
- 3.4.3. Blood Banks and Blood Centers
- 3.4.4. Research and Diagnostic Laboratories
3.5. Global Platelet and Plasma Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa

4. North America Platelet and Plasma Market Outlook, 2020-2033

4.1. North America Platelet and Plasma Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 4.1.1. Platelet Concentrates
- 4.1.2. Fresh Frozen Plasma and Plasma for Transfusion
- 4.1.3. Source Plasma for Fractionation
- 4.1.4. Cryoprecipitate and Other Plasma Components
4.2. North America Platelet and Plasma Market Outlook, by Collection Method, Value (US$ Bn), 2020-2033
- 4.2.1. Apheresis Collection
- 4.2.2. Whole Blood Derived Collection
- 4.2.3. Hybrid and Automated Multicomponent Collection
4.3. North America Platelet and Plasma Market Outlook, by Processing Technology, Value (US$ Bn), 2020-2033
- 4.3.1. Conventional Processing and Leukoreduction
- 4.3.2. Pathogen Reduction Technology
- 4.3.3. Cold-Stored and Extended Shelf-Life Platelets
- 4.3.4. Freeze-Dried and Lyophilized Plasma
4.4. North America Platelet and Plasma Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.4.1. Plasma Fractionation Companies
- 4.4.2. Hospitals and Transfusion Services
- 4.4.3. Blood Banks and Blood Centers
- 4.4.4. Research and Diagnostic Laboratories
4.5. North America Platelet and Plasma Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 4.5.2. U.S. Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 4.5.3. U.S. Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 4.5.4. U.S. Platelet and Plasma Market Outlook, by End User, 2020-2033
- 4.5.5. Canada Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 4.5.6. Canada Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 4.5.7. Canada Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 4.5.8. Canada Platelet and Plasma Market Outlook, by End User, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Platelet and Plasma Market Outlook, 2020-2033

5.1. Europe Platelet and Plasma Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 5.1.1. Platelet Concentrates
- 5.1.2. Fresh Frozen Plasma and Plasma for Transfusion
- 5.1.3. Source Plasma for Fractionation
- 5.1.4. Cryoprecipitate and Other Plasma Components
5.2. Europe Platelet and Plasma Market Outlook, by Collection Method, Value (US$ Bn), 2020-2033
- 5.2.1. Apheresis Collection
- 5.2.2. Whole Blood Derived Collection
- 5.2.3. Hybrid and Automated Multicomponent Collection
5.3. Europe Platelet and Plasma Market Outlook, by Processing Technology, Value (US$ Bn), 2020-2033
- 5.3.1. Conventional Processing and Leukoreduction
- 5.3.2. Pathogen Reduction Technology
- 5.3.3. Cold-Stored and Extended Shelf-Life Platelets
- 5.3.4. Freeze-Dried and Lyophilized Plasma
5.4. Europe Platelet and Plasma Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.4.1. Plasma Fractionation Companies
- 5.4.2. Hospitals and Transfusion Services
- 5.4.3. Blood Banks and Blood Centers
- 5.4.4. Research and Diagnostic Laboratories
5.5. Europe Platelet and Plasma Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 5.5.2. Germany Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 5.5.3. Germany Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 5.5.4. Germany Platelet and Plasma Market Outlook, by End User, 2020-2033
- 5.5.5. Italy Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 5.5.6. Italy Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 5.5.7. Italy Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 5.5.8. Italy Platelet and Plasma Market Outlook, by End User, 2020-2033
- 5.5.9. France Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 5.5.10. France Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 5.5.11. France Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 5.5.12. France Platelet and Plasma Market Outlook, by End User, 2020-2033
- 5.5.13. U.K. Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 5.5.14. U.K. Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 5.5.15. U.K. Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 5.5.16. U.K. Platelet and Plasma Market Outlook, by End User, 2020-2033
- 5.5.17. Spain Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 5.5.18. Spain Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 5.5.19. Spain Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 5.5.20. Spain Platelet and Plasma Market Outlook, by End User, 2020-2033
- 5.5.21. Russia Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 5.5.22. Russia Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 5.5.23. Russia Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 5.5.24. Russia Platelet and Plasma Market Outlook, by End User, 2020-2033
- 5.5.25. Rest of Europe Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 5.5.26. Rest of Europe Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 5.5.27. Rest of Europe Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 5.5.28. Rest of Europe Platelet and Plasma Market Outlook, by End User, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Platelet and Plasma Market Outlook, 2020-2033

6.1. Asia Pacific Platelet and Plasma Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 6.1.1. Platelet Concentrates
- 6.1.2. Fresh Frozen Plasma and Plasma for Transfusion
- 6.1.3. Source Plasma for Fractionation
- 6.1.4. Cryoprecipitate and Other Plasma Components
6.2. Asia Pacific Platelet and Plasma Market Outlook, by Collection Method, Value (US$ Bn), 2020-2033
- 6.2.1. Apheresis Collection
- 6.2.2. Whole Blood Derived Collection
- 6.2.3. Hybrid and Automated Multicomponent Collection
6.3. Asia Pacific Platelet and Plasma Market Outlook, by Processing Technology, Value (US$ Bn), 2020-2033
- 6.3.1. Conventional Processing and Leukoreduction
- 6.3.2. Pathogen Reduction Technology
- 6.3.3. Cold-Stored and Extended Shelf-Life Platelets
- 6.3.4. Freeze-Dried and Lyophilized Plasma
6.4. Asia Pacific Platelet and Plasma Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.4.1. Plasma Fractionation Companies
- 6.4.2. Hospitals and Transfusion Services
- 6.4.3. Blood Banks and Blood Centers
- 6.4.4. Research and Diagnostic Laboratories
6.5. Asia Pacific Platelet and Plasma Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 6.5.2. China Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 6.5.3. China Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 6.5.4. China Platelet and Plasma Market Outlook, by End User, 2020-2033
- 6.5.5. Japan Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 6.5.6. Japan Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 6.5.7. Japan Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 6.5.8. Japan Platelet and Plasma Market Outlook, by End User, 2020-2033
- 6.5.9. South Korea Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 6.5.10. South Korea Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 6.5.11. South Korea Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 6.5.12. South Korea Platelet and Plasma Market Outlook, by End User, 2020-2033
- 6.5.13. India Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 6.5.14. India Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 6.5.15. India Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 6.5.16. India Platelet and Plasma Market Outlook, by End User, 2020-2033
- 6.5.17. Southeast Asia Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 6.5.18. Southeast Asia Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 6.5.19. Southeast Asia Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 6.5.20. Southeast Asia Platelet and Plasma Market Outlook, by End User, 2020-2033
- 6.5.21. Rest of SAO Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 6.5.22. Rest of SAO Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 6.5.23. Rest of SAO Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 6.5.24. Rest of SAO Platelet and Plasma Market Outlook, by End User, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Platelet and Plasma Market Outlook, 2020-2033

7.1. Latin America Platelet and Plasma Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 7.1.1. Platelet Concentrates
- 7.1.2. Fresh Frozen Plasma and Plasma for Transfusion
- 7.1.3. Source Plasma for Fractionation
- 7.1.4. Cryoprecipitate and Other Plasma Components
7.2. Latin America Platelet and Plasma Market Outlook, by Collection Method, Value (US$ Bn), 2020-2033
- 7.2.1. Apheresis Collection
- 7.2.2. Whole Blood Derived Collection
- 7.2.3. Hybrid and Automated Multicomponent Collection
7.3. Latin America Platelet and Plasma Market Outlook, by Processing Technology, Value (US$ Bn), 2020-2033
- 7.3.1. Conventional Processing and Leukoreduction
- 7.3.2. Pathogen Reduction Technology
- 7.3.3. Cold-Stored and Extended Shelf-Life Platelets
- 7.3.4. Freeze-Dried and Lyophilized Plasma
7.4. Latin America Platelet and Plasma Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.4.1. Plasma Fractionation Companies
- 7.4.2. Hospitals and Transfusion Services
- 7.4.3. Blood Banks and Blood Centers
- 7.4.4. Research and Diagnostic Laboratories
7.5. Latin America Platelet and Plasma Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 7.5.2. Brazil Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 7.5.3. Brazil Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 7.5.4. Brazil Platelet and Plasma Market Outlook, by End User, 2020-2033
- 7.5.5. Mexico Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 7.5.6. Mexico Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 7.5.7. Mexico Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 7.5.8. Mexico Platelet and Plasma Market Outlook, by End User, 2020-2033
- 7.5.9. Argentina Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 7.5.10. Argentina Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 7.5.11. Argentina Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 7.5.12. Argentina Platelet and Plasma Market Outlook, by End User, 2020-2033
- 7.5.13. Rest of LATAM Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 7.5.14. Rest of LATAM Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 7.5.15. Rest of LATAM Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 7.5.16. Rest of LATAM Platelet and Plasma Market Outlook, by End User, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Platelet and Plasma Market Outlook, 2020-2033

8.1. Middle East & Africa Platelet and Plasma Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 8.1.1. Platelet Concentrates
- 8.1.2. Fresh Frozen Plasma and Plasma for Transfusion
- 8.1.3. Source Plasma for Fractionation
- 8.1.4. Cryoprecipitate and Other Plasma Components
8.2. Middle East & Africa Platelet and Plasma Market Outlook, by Collection Method, Value (US$ Bn), 2020-2033
- 8.2.1. Apheresis Collection
- 8.2.2. Whole Blood Derived Collection
- 8.2.3. Hybrid and Automated Multicomponent Collection
8.3. Middle East & Africa Platelet and Plasma Market Outlook, by Processing Technology, Value (US$ Bn), 2020-2033
- 8.3.1. Conventional Processing and Leukoreduction
- 8.3.2. Pathogen Reduction Technology
- 8.3.3. Cold-Stored and Extended Shelf-Life Platelets
- 8.3.4. Freeze-Dried and Lyophilized Plasma
8.4. Middle East & Africa Platelet and Plasma Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.4.1. Plasma Fractionation Companies
- 8.4.2. Hospitals and Transfusion Services
- 8.4.3. Blood Banks and Blood Centers
- 8.4.4. Research and Diagnostic Laboratories
8.5. Middle East & Africa Platelet and Plasma Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 8.5.2. GCC Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 8.5.3. GCC Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 8.5.4. GCC Platelet and Plasma Market Outlook, by End User, 2020-2033
- 8.5.5. South Africa Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 8.5.6. South Africa Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 8.5.7. South Africa Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 8.5.8. South Africa Platelet and Plasma Market Outlook, by End User, 2020-2033
- 8.5.9. Egypt Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 8.5.10. Egypt Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 8.5.11. Egypt Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 8.5.12. Egypt Platelet and Plasma Market Outlook, by End User, 2020-2033
- 8.5.13. Nigeria Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 8.5.14. Nigeria Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 8.5.15. Nigeria Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 8.5.16. Nigeria Platelet and Plasma Market Outlook, by End User, 2020-2033
- 8.5.17. Rest of Middle East Platelet and Plasma Market Outlook, by Product Type, 2020-2033
- 8.5.18. Rest of Middle East Platelet and Plasma Market Outlook, by Collection Method, 2020-2033
- 8.5.19. Rest of Middle East Platelet and Plasma Market Outlook, by Processing Technology, 2020-2033
- 8.5.20. Rest of Middle East Platelet and Plasma Market Outlook, by End User, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Grifols, S.A.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. CSL Limited
- 9.4.3. Takeda Pharmaceutical Company Limited
- 9.4.4. Octapharma AG
- 9.4.5. Terumo Blood and Cell Technologies
- 9.4.6. Haemonetics Corporation
- 9.4.7. Fresenius Kabi AG
- 9.4.8. Cerus Corporation
- 9.4.9. Macopharma SAS
- 9.4.10. Kedrion S.p.A.

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Platelet and Plasma Market Insights, Competitive Landscape, and Market Forecast - 2033